Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Clinical Nutrition for Diabetes Care Market

Clinical Nutrition for Diabetes Care Market Size

  • Report ID: GMI10070
  • Published Date: Jul 2024
  • Report Format: PDF

Clinical Nutrition for Diabetes Care Market Size

Clinical Nutrition for Diabetes Care Market size accounted for USD 2.2 billion in 2023 and is anticipated to witness growth at 4.8% of CAGR from 2024 and 2032. This market growth is primarily driven by the rising prevalence of diabetes, increased awareness of the importance of nutrition in diabetes management, and advancements in nutritional science and product formulation.

 

As diabetes, particularly type 2 Diabetes, becomes more prevalent globally, there is a growing demand for specialized nutritional products that help manage blood glucose levels, support overall health, and prevent complications. Therefore, the increasing prevalence of diabetes is a major factor driving market growth.
 

Additionally, advancements in nutritional science have led to the development of more effective and palatable products, further boosting market expansion. These advancements include the formulation of specialized products catering to specific needs, such as high-protein, low-carbohydrate, and fiber-enriched options, which enhance diabetes management.
 

Clinical nutrition for diabetes care refers to specialized dietary management aimed at maintaining optimal blood glucose levels and overall health in individuals with diabetes. This involves tailored nutritional strategies and products, such as low-glycemic index foods, meal replacements, and enteral or parenteral nutrition solutions, designed to meet the unique metabolic needs of diabetic patients. The goal is to control blood sugar spikes, prevent complications, and ensure adequate intake of essential nutrients.       

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Clinical nutrition for diabetes care industry reached a revenue of USD 2.2 billion in 2023 and is anticipated to witness 4.8% CAGR from 2024 to 2032, primarily driven by the rising prevalence of diabetes and the increased awareness of the importance of nutrition in diabetes management.

The oral nutrition segment accounted for 65.2% of the market share in 2023, as they are more cost-effective than parenteral or enteral nutrition.

North America clinical nutrition for diabetes care industry accounted for USD 922.1 million in revenue in 2023 and may grow at 4.6% CAGR between 2024 – 2032, led by significant investments in diabetes management and related healthcare services.

Abbott Laboratories, Baxter International Inc., Danone Nutricia, Dr Reddy's Laboratories Ltd., Mead Johnson & Company, LLC, Nestlé Health Science S.A., Nutrego, Otsuka Holdings Co., Ltd., Pfizer Inc., Prohance, and Victus, Inc.

Clinical Nutrition for Diabetes Care Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 677
  • Countries covered: 22
  • Pages: 395
 Download Free Sample